Schonfeld Strategic Advisors »

Abcellera Biologics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $67k 20k 3.42
2023-09-30 $1.6M 358k 4.60
2023-06-30 $952k 147k 6.46
2023-03-31 $618k 82k 7.54
2022-12-31 $1.6M 155k 10.13
2022-09-30 $2.2M 223k 9.89
2022-06-30 $1.5M 138k 10.65
2022-03-31 $1.2M 124k 9.75
2021-09-30 $1.2M 58k 20.04

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr China Lg-cap Etf (FXI)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Schonfeld Strategic Advisors

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Ubs Global Asset Management Americas
Two Sigma Investments
Two Sigma Advisers
Goldman Sachs Group
Arrowpoint Asset Management
BlackRock
Millennium Management
Renaissance Technologies
Susquehanna International
UBS Group
Guardian Partners
Driehaus Capital Management
Jane Street

View all funds holding Abcellera Biologics